These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1019 related items for PubMed ID: 27480651

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Thiotepa-Based Intensified Reduced-Intensity Conditioning Adult Double-Unit Cord Blood Hematopoietic Stem Cell Transplantation Results in Decreased Relapse Rate and Improved Survival Compared with Transplantation Following Standard Reduced-Intensity Conditioning: A Retrospective Cohort Comparison.
    Sharma P, Pollyea DA, Smith CA, Purev E, Kamdar M, Haverkos B, Sherbenou D, Rabinovitch R, Hammes A, Gutman JA.
    Biol Blood Marrow Transplant; 2018 Aug; 24(8):1671-1677. PubMed ID: 29684565
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Effect of BU and CY versus TBI and CY as conditioning regimens on the efficacy of haploidentical stem cell transplantation in patients with hematologic malignancy].
    Shao Q, Han D, Liu D, Zheng X, Dong L, Wang Z, Ding L, Yan H, Wang H, Duan L.
    Zhonghua Xue Ye Xue Za Zhi; 2014 Jun; 35(6):505-10. PubMed ID: 24985173
    [Abstract] [Full Text] [Related]

  • 27. [Treatment of Gaucher disease with allogeneic hematopoietic stem cell transplantation: report of three cases and review of literatures].
    Tang X, Luan Z, Wu N, Zhang B, Jing Y, Du H, Lu W, Xu S.
    Zhonghua Er Ke Za Zhi; 2015 Nov; 53(11):810-6. PubMed ID: 26758318
    [Abstract] [Full Text] [Related]

  • 28. Outcome of Fludarabine-Based Conditioning in High-Risk Aplastic Anemia Patients Undergoing Matched Related Donor Transplantation: A Single-Center Study from Pakistan.
    Chaudhry QUN, Iftikhar R, Satti TM, Mahmood SK, Ghafoor T, Shamshad GU, Farhan M, Shahbaz N, Khan MA, Khattak TA, Rehman J, Humayun S, Satti HS, Anwer F, Ahmed P.
    Biol Blood Marrow Transplant; 2019 Dec; 25(12):2375-2382. PubMed ID: 31394274
    [Abstract] [Full Text] [Related]

  • 29. Unrelated umbilical cord blood transplantation using a TBI/FLAG conditioning regimen for adults with hematologic malignancies.
    Okada M, Fujimori Y, Misawa M, Kai S, Nakajima T, Okikawa Y, Satake A, Itoi H, Takatsuka H, Itsukuma T, Nishioka K, Tamaki H, Ikegame K, Hara H, Ogawa H.
    Biol Blood Marrow Transplant; 2008 Aug; 14(8):896-903. PubMed ID: 18640573
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Comparison of outcomes after two standards-of-care reduced-intensity conditioning regimens and two different graft sources for allogeneic stem cell transplantation in adults with hematologic diseases: a single-center analysis.
    Le Bourgeois A, Mohr C, Guillaume T, Delaunay J, Malard F, Loirat M, Peterlin P, Blin N, Dubruille V, Mahe B, Gastinne T, Le Gouill S, Moreau P, Mohty M, Planche L, Lode L, Bene MC, Chevallier P.
    Biol Blood Marrow Transplant; 2013 Jun; 19(6):934-9. PubMed ID: 23523970
    [Abstract] [Full Text] [Related]

  • 32. [Umbilical cord blood cell transplantation from an unrelated donor: dual transplantation].
    Bautista G, Regidor C, Gonzalo-Daganzo R, Cabrera JR.
    Methods Find Exp Clin Pharmacol; 2010 Dec; 32 Suppl A():47-51. PubMed ID: 21381288
    [Abstract] [Full Text] [Related]

  • 33. A retrospective comparison of cyclophosphamide plus antithymocyte globulin with cyclophosphamide plus busulfan as the conditioning regimen for severe aplastic anemia.
    Ommati LV, Rodrigues CA, Silva AR, Silva LP, Chaufaille ML, Oliveira JS.
    Braz J Med Biol Res; 2009 Mar; 42(3):244-50. PubMed ID: 19287903
    [Abstract] [Full Text] [Related]

  • 34. [Clinical study of double units unrelated cord blood transplantation in adult patients with hematological malignancies].
    Yin Y, Ren HY, Cen XN, Qiu ZX, Ou JP, Wang WS, Xu WL, Wang MJ, Wang LH, Li Y.
    Zhonghua Xue Ye Xue Za Zhi; 2008 Feb; 29(2):73-7. PubMed ID: 18681304
    [Abstract] [Full Text] [Related]

  • 35. A 5-day cytoreductive chemotherapy followed by haplo-identical hsct (FA5-BUCY) as a tumor-ablative regimen improved the survival of patients with advanced hematological malignancies.
    Yang T, Lin Q, Ren J, Chen P, Yuan X, Luo X, Liu T, Zheng J, Zheng Z, Zheng X, Chen X, Zhang L, Zheng H, Chen Z, Hua X, Le S, Li J, Chen Z, Hu J.
    Oncotarget; 2016 Nov 29; 7(48):78773-78786. PubMed ID: 27705929
    [Abstract] [Full Text] [Related]

  • 36. [Single non-blood-related umbilical cord blood transplantation using a reduced-intensity conditioning regimen for the treatment of severe aplastic anemia].
    Wu Y, Tang BL, Song KD, Sun GY, Pan TZ, Huang AJ, Yan BB, Zhu XY.
    Zhonghua Xue Ye Xue Za Zhi; 2024 Jan 14; 45(1):68-73. PubMed ID: 38527841
    [Abstract] [Full Text] [Related]

  • 37. Impact of in vivo T cell depletion in HLA-identical allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission conditioned with a fludarabine iv-busulfan myeloablative regimen: a report from the EBMT Acute Leukemia Working Party.
    Rubio MT, D'Aveni-Piney M, Labopin M, Hamladji RM, Sanz MA, Blaise D, Ozdogu H, Daguindeau E, Richard C, Santarone S, Irrera G, Yakoub-Agha I, Yeshurun M, Diez-Martin JL, Mohty M, Savani BN, Nagler A.
    J Hematol Oncol; 2017 Jan 24; 10(1):31. PubMed ID: 28118857
    [Abstract] [Full Text] [Related]

  • 38. A New Conditioning Regimen Can Significantly Promote Post-Transplant Immune Reconstitution and Improve the Outcome of Umbilical Cord Blood Transplantation for Patients.
    Yu ZP, Ding JH, Sun AN, Chen BA, Ge Z, Wu DP.
    Stem Cells Dev; 2019 Oct 15; 28(20):1376-1383. PubMed ID: 31464164
    [Abstract] [Full Text] [Related]

  • 39. [The efficacy and safety of modified busulfan/fludarabine conditioning regimen in elderly or drug-intolerable patients with hematologic malignancies].
    Wang FR, Huang XJ, Liu DH, Chen H, Wang Y, Tang FF, Sun YQ, Fu HX, Liu KY, Xu LP.
    Zhonghua Nei Ke Za Zhi; 2013 Dec 15; 52(12):1028-32. PubMed ID: 24503400
    [Abstract] [Full Text] [Related]

  • 40. Busulfan dose intensity and outcomes in reduced-intensity allogeneic peripheral blood stem cell transplantation for myelodysplastic syndrome or acute myeloid leukemia.
    Chen YB, Coughlin E, Kennedy KF, Alyea EP, Armand P, Attar EC, Ballen KK, Cutler C, Dey BR, Koreth J, McAfee SL, Spitzer TR, Antin JH, Soiffer RJ, Ho VT.
    Biol Blood Marrow Transplant; 2013 Jun 15; 19(6):981-7. PubMed ID: 23562738
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 51.